Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aquaox is a healthcare technology company specializing in the on-site generation of high-purity Hypochlorous Acid (HOCl) through its proprietary Electrochemical Activation (ECA) platform. The company provides automated systems that produce non-toxic, eco-friendly disinfectants and sanitizers for use in hospitals, dental offices, and industrial settings. Aquaox's solutions are designed to effectively eliminate a broad spectrum of pathogens and biofilms while remaining safe for humans and the environment. Their technology is widely utilized for infection prevention, wound care, and water treatment applications. By enabling on-site production, Aquaox reduces the need for transporting and storing hazardous chemicals, offering a sustainable alternative to traditional disinfection methods. The company's systems are recognized for their ability to produce stable, pH-neutral HOCl, which is highly effective against multi-drug resistant organisms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PureAquaox.